Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-15,615
Closed -$954K 585
2017
Q3
$954K Buy
+15,615
New +$947K 0.04% 341
2017
Q2
Sell
-7,126
Closed -$432K 967
2017
Q1
$432K Buy
+7,126
New +$432K 0.01% 720
2016
Q4
Sell
-12,576
Closed -$749K 797
2016
Q3
$749K Buy
12,576
+3,144
+33% +$184K 0.02% 421
2016
Q2
$518K Sell
9,432
-68,015
-88% -$3.62M 0.02% 412
2016
Q1
$3.91M Buy
+77,447
New +$3.79M 0.11% 226
2014
Q2
Sell
-37,728
Closed -$2.04M 689
2014
Q1
$2.04M Buy
+37,728
New +$1.95M 0.11% 191

Other funds holding MRK

Hutchin Hill Capital's MRK Position: Q4 2017 in Review

Hutchin Hill Capital sold out of Merck (MRK) in Q4 2017, closing a stake of 15,615 shares — an estimated $954K sold.

Hutchin Hill Capital first reported a position in MRK in Q1 2014 and held it in 6 quarters. The position peaked at $3.91M in Q1 2016. 2,009 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • Hutchin Hill Capital reported no remaining Merck position as of Q4 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 15,615 Merck shares in Q4 2017, an estimated $954K.
  • Hutchin Hill Capital first reported a position in Merck in Q1 2014 and held it in 6 quarters.
  • Hutchin Hill Capital's Merck position peaked at $3.91M in Q1 2016.
  • 2,009 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.